2,295 Shares in Danaher Corporation $DHR Bought by Index Fund Advisors Inc.

Key Points

• Index Fund Advisors Inc. has acquired 2,295 shares of Danaher Corporation valued at approximately $453,000 during the second quarter.
• Danaher reported $1.80 earnings per share for the last quarter, exceeding analysts' expectations, with revenue up 3.4% year-over-year.
• The company has announced a quarterly dividend of $0.32 per share, set to be paid on October 31st, reflecting a 0.6% dividend yield.

Index Fund Advisors Inc. purchased a new stake in Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,295 shares of the conglomerate's stock, valued at approximately $453,000.

Several other institutional investors and hedge funds have also made changes to their positions in DHR. MGO One Seven LLC lifted its stake in Danaher by 485.7% during the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after purchasing an additional 20,813 shares during the last quarter. Chicago Capital LLC raised its holdings in Danaher by 11.6% during the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate's stock worth $2,634,000 after purchasing an additional 1,391 shares in the last quarter. UniSuper Management Pty Ltd lifted its position in shares of Danaher by 1.6% during the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate's stock worth $34,954,000 after buying an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. acquired a new position in shares of Danaher in the 1st quarter valued at $539,000. Finally, Horizon Financial Services LLC grew its position in shares of Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after buying an additional 8,160 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Down 1.0%

NYSE DHR opened at $202.53 on Monday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41. The firm has a 50-day moving average price of $200.66 and a 200 day moving average price of $197.07. The stock has a market capitalization of $145.02 billion, a P/E ratio of 43.09, a P/E/G ratio of 2.88 and a beta of 0.77. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company's revenue for the quarter was up 3.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher's payout ratio is presently 27.23%.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms have issued reports on DHR. Rothschild Redb downgraded shares of Danaher from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, October 8th. Robert W. Baird boosted their target price on Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a report on Friday, July 18th. Barclays reaffirmed an "overweight" rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Wells Fargo & Company decreased their price objective on Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a report on Wednesday, July 23rd. Finally, Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a research report on Friday, July 11th. Seventeen analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $244.60.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.